Leuprolide acetate is a synthetic nine - peptide analogue of gonadotropin - releasing hormone. Leuprolide acetate is also known as Leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty. It is given by injection into a muscle or under the skin.It is used to treat hormone-reactive cancers, such as prostate and breast cancer.It can also be used for estrogen-dependent conditions, such as endometriosis or uterine fibroids.
This report contains market size and forecasts of Leuprorelin Acetate in global, including the following market information:
Global Leuprorelin Acetate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Leuprorelin Acetate Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Leuprorelin Acetate companies in 2021 (%)
The global Leuprorelin Acetate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1.88 mg Preparation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Leuprorelin Acetate include Merck, Takeda, MediGene, Livzon Pharmaceutical Group and Bejing Biote Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Leuprorelin Acetate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Leuprorelin Acetate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Leuprorelin Acetate Market Segment Percentages, by Type, 2021 (%)
1.88 mg Preparation
2.75 mg Preparation
3.75 mg Preparation
Global Leuprorelin Acetate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Leuprorelin Acetate Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Leuprorelin Acetate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Leuprorelin Acetate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Leuprorelin Acetate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Leuprorelin Acetate revenues share in global market, 2021 (%)
Key companies Leuprorelin Acetate sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Leuprorelin Acetate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Takeda
MediGene
Livzon Pharmaceutical Group
Bejing Biote Pharmaceutical